These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16912581)
21. Comparison of single-entry and double-entry two-step couple screening for cystic fibrosis carriers. ten Kate LP; Verheij JB; Wildhagen MF; Hilderink HB; Kooij L; Verzijl JG; Habbema JD Hum Hered; 1996; 46(1):20-5. PubMed ID: 8825458 [TBL] [Abstract][Full Text] [Related]
22. Carrier screening for thalassemia and hemoglobinopathies in Canada. Langlois S; Ford JC; Chitayat D; ; J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079 [TBL] [Abstract][Full Text] [Related]
23. Population screening for cystic fibrosis. Brock DJ Curr Opin Pediatr; 1996 Dec; 8(6):635-8. PubMed ID: 9018450 [TBL] [Abstract][Full Text] [Related]
24. Teaching about cystic fibrosis carrier screening by using written and video information. Clayton EW; Hannig VL; Pfotenhauer JP; Parker RA; Campbell PW; Phillips JA Am J Hum Genet; 1995 Jul; 57(1):171-81. PubMed ID: 7611285 [TBL] [Abstract][Full Text] [Related]
25. Prenatal screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women? Mennie ME; Axworthy D; Liston WA; Brock DJ Prenat Diagn; 1997 Sep; 17(9):853-60. PubMed ID: 9316130 [TBL] [Abstract][Full Text] [Related]
26. Antenatal screening for cystic fibrosis: a trial of the couple model. Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277 [TBL] [Abstract][Full Text] [Related]
27. Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening. Modra LJ; Massie RJ; Delatycki MB Med J Aust; 2010 Aug; 193(3):157-60. PubMed ID: 20678044 [TBL] [Abstract][Full Text] [Related]
29. Cystic fibrosis carrier population screening in the primary care setting. Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530 [TBL] [Abstract][Full Text] [Related]
30. Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening. Hinton CF; Grant AM; Grosse SD Ethn Health; 2011; 16(4-5):377-88. PubMed ID: 21797724 [TBL] [Abstract][Full Text] [Related]
31. [Preconceptional carrier screening should not be delayed]. Cornel MC; Lakeman P; Dondorp W Ned Tijdschr Geneeskd; 2011; 155():A3205. PubMed ID: 21504638 [TBL] [Abstract][Full Text] [Related]
32. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264 [TBL] [Abstract][Full Text] [Related]
36. Cascade testing for carrier status in cystic fibrosis in a large family. Turner G; Meagher W; Willis C; Colley P Med J Aust; 1993 Aug; 159(3):163-5. PubMed ID: 8336615 [TBL] [Abstract][Full Text] [Related]
38. Planning the development of cystic fibrosis gene carrier screening. Beech R; Bekker H J Health Serv Res Policy; 1996 Apr; 1(2):81-92. PubMed ID: 10180854 [TBL] [Abstract][Full Text] [Related]
39. Preconceptional cystic fibrosis carrier screening: opinions of general practitioners, gynecologists, and pediatricians in the Netherlands. Baars MJ; Henneman L; ten Kate LP Genet Test; 2004; 8(4):431-6. PubMed ID: 15684876 [TBL] [Abstract][Full Text] [Related]
40. Complex phenotypes in the haemoglobinopathies: recommendations on screening and DNA testing. Trent RJ; Webster B; Bowden DK; Gilbert A; Holl PJ; Lindeman R; Lammi A; Rowell J; Hinchcliffe M; Colley A; Wilson M; Saleh M; Blackwell J; Petrou V Pathology; 2006 Dec; 38(6):507-19. PubMed ID: 17393977 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]